Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 51 - 53 of 53 in total

Methyclothiazide

A thiazide diuretic with properties similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p825)
Withdrawn
Matched Categories: … Sulfur Compounds ... methyclothiazide and potassium …

Lobeglitazone

Lobeglitazone is an antidiabetic medication from the thiazolidinedione class of drugs. It primarily functions as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated Receptors (PPAR) gamma within fat cells. By activating PPAR-gamma and promoting the binding of insulin at fat cells, lobeglitazone thereby has been shown to reduce blood...
Experimental
Matched Description: … It primarily functions as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated ... been shown to reduce blood sugar levels, lower hemoglobain A1C (HbA1C) levels, and improve lipid and ... Lobeglitazone was approved by the Ministry of Food and Drug Safety (South Korea) in 2013, and is being …
Matched Categories: … Sulfur Compounds ... Alimentary Tract and Metabolism ... metformin and lobeglitazone …

Perospirone

Perospirone is an atypical or second-generation antipsychotic of the azapirone family that antagonizes serotonin 5HT2A receptors and dopamine D2 receptors. It also displays affinity towards 5HT1A receptors as a partial agonist. Dainippon Sumitomo Pharma developed perospirone in Japan in 2001 for the treatment of acute schizophrenia and bipolar mania as...
Experimental
Matched Description: … second-generation antipsychotic of the azapirone family that antagonizes serotonin 5HT2A receptors and ... Classified as a neuroleptic agent, perospirone is shown to be effective against positive, negative and ... Dainippon Sumitomo Pharma developed perospirone in Japan in 2001 for the treatment of acute schizophrenia and …
Matched Categories: … Sulfur Compounds …
Displaying drugs 51 - 53 of 53 in total